Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20160524028038N17
IRCT20160524028038N17
Recruiting
Phase 3

Evaluation of the effect of myoinositol on the sexual function of patients with polycystic ovary syndrome treated with cyproterone compound

Yasouj University of Medical Sciences0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Polycystic ovarian syndrome.
Sponsor
Yasouj University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Yasouj University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •age 18 to 40 years
  • •Confirmation of polycystic ovary syndrome based on the Rotterdam criteria
  • •Absence of severe mental conditions since six months before the research
  • •Not suffering from severe depression and anxiety according to the depression and anxiety questionnaire
  • •No current use of psychiatric medications
  • •No language or cognitive problems preventing the patient from completing the questionnaire
  • •No current use of drugs affecting sexual function
  • •Failure to previously diagnose an organic cause for sexual dysfunction by an experienced physician
  • •Currently taking cyproterone compound tablets as prescribed by the gynecologist

Exclusion Criteria

  • •Patients who do not want to cooperate.
  • •Pregnancy during study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Assesment the clinical effect of myoinositol on insulin resistence in women with PCOSPolycystic Ovarian Syndrome.Ovarian dysfunction, unspecified
IRCT2015010319426N4Vice chancellor for research, Shahid Beheshti University of Medical Science50
Completed
Not Applicable
Effect of Myoinositol Treatment of Spermatozoa on in Vitro Fertilization OutcomeCouple Sterility
NCT02050672AGUNCO Obstetrics and Gynecology Centre249
Not yet recruiting
Phase 3
The effect of Myoinositol on the outcomes of assisted reproductive treatments in patients with polycystic ovary syndromeFemale infertility associated with anovulation.Female infertility associated with anovulationN97.0
IRCT20240119060732N2Tehran University of Medical Sciences98
Completed
Phase 3
The effect of myoinositol supplementation on the prevention of gestational diabetes mellitusGestational diabetes mellitus (GDM).Gestational diabetes mellitusO24.4
IRCT20120826010664N4Tehran University of Medical Sciences276
Completed
Phase 3
The Effect of Myo-inositol on fertility rates in Poor ovarian Responder Women undergoing Assisted Reproductive technique
IRCT20180515039668N1Bandare-abbas University of Medical Sciences60